Revenue Performance: Q4 2024 revenue reached $229.9 million, up 24.81% YOY and 22.06% QoQ. This increase reflects effective product strategies in both cannabis and wellness sectors.
Profitability: Although revenues rose, the net income showed a loss of $31.7 million, significantly better than the previous quarter, highlighting ongoing challenges in managing costs but with an improvement in operational efficiency. The EBITDA margin stands at 4.7%, reflecting constraints in cost management and market conditions.
Balance Sheet Health: Total assets amount to $4.34 billion, with total liabilities of $892.2 million, resulting in a solid equity base of $3.44 billion. The debt-to-equity ratio remains low at 0.113, indicating a conservative approach to leverage which is beneficial in turbulent markets.
Cash Flow: Net cash from operating activities was $31.1 million, demonstrating robust operational cash flow management despite operational losses. The ending cash position improved $82 million, totaling $228.34 million, enhancing liquidity and providing resources for strategic initiatives.
Performance Metrics: Current ratio stands at 2.27, exceeding the industry benchmark, which indicates strong liquidity and operational efficiency.